Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Hits & Misses
    • Artificial Intelligence and Healthcare
    • Doctors & Hospitals
      • COVID-19 and Public Health
    • Policy & Legislation
      • Affordable Care Act
    • Health Economics & Costs
      • Cost of Healthcare
      • Drug Prices & Regulations
      • Health Reform
    • Health Insurance
      • Public Insurance
      • Medicare
    • Telemedicine
      • Medical Tourism
  • Goodman Institute
  • Contact
  • Search
The Goodman Institute Health Blog

Category: Health Economics & Costs

Women May Lose Access to Autoimmune Drug That is Also Used in Abortions

Posted on July 6, 2022 by Devon Herrick

Methotrexate is a chemotherapy drug used to treat various autoimmune diseases including rheumatoid arthritis, lupus and in higher doses some cancers. Methotrexate is not safe to take during pregnancy. It can cause birth defects and is also used to end life-threatening ectopic pregnancies. When paired with the drug misoprostol it is used to induce a medical abortion. 

+

What Doctors are Doing, and Why

Posted on July 4, 2022 by John C. Goodman

Is the practice of medicine being dictated by billing codes?

Several decades ago … physicians wrote “notes” on their patients…. every patient had a chart, and physicians would make notes following each patient encounter, capturing such elements as past medical history, the story of the present illness, the findings of physical examination and laboratory testing, and plans for further diagnostic evaluation and care. This approach required the physician to think everything through and formulate a coherent plan. In a sense, every physician was a storyteller, and one of the signs of excellence was the ability to formulate a succinct but comprehensive and coherent account of the patient’s care.

Today, by contrast, a great deal of the medical record is composed by selecting items from lists of available choices and drop-down menus…. And in most cases, the lists of options are constructed as much or more for coding and billing purposes—making sure the practice or hospital complies with regulations and gets paid—as they are to foster good patient care.

+

Why Don’t People Trust the CDC?

Posted on July 3, 2022 by John C. Goodman

Consider the CDC studies on school mask mandates, which have uniformly claimed benefits. Two researchers at the University of Toronto and University of California, Davis recently sought to replicate a CDC study that found that pediatric Covid cases increased faster in U.S. counties that didn’t have school mask mandates compared with those that did….

As another example, recall the CDC’s widely cited studies last fall that purportedly found vaccines provide better protection than natural immunity from infection…. But a new study, published this month in the New England Journal of Medicine, finds that natural immunity provides more-durable and stronger protection than vaccines.

Allysia Finley in the WSJ

+

Health Plans Now Required to Post Prices. Will it Help?

Posted on July 1, 2022 by Devon Herrick

An article in Kaiser Health News explained that health plans are now required to post the prices they have negotiated with all in-network health care providers. Failing to do so will result in substantial fines. The new rule is the result of an executive order then President Trump issued back in 2019.

Price transparency is the holy grail in health policy. There is not one price, but many prices depending on who the payer is. There is the list price that nobody pays unless uninsured and caught off-guard. There’s the cash price paid after receiving care. It is often same as the list price. Then there is the (lower) negotiated cash price if uninsured and paid in advance of receiving care. Then there are the prices Medicare pays and Medicaid pays. Health insurers may all have different prices for the same procedures. Indeed, prices vary tremendously across facilities. A knee replacement may be $30,000 at one hospital and $130,000 at another.

+
  • Previous
  • 1
  • …
  • 492
  • 493
  • 494
  • 495
  • 496
  • 497
  • 498
  • …
  • 516
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 45 other subscribers

Popular Topics

©2026 The Goodman Institute Health Blog | Website by Lexicom